ALAUNOS THERAPEUTICS INC (TCRT) Stock Analyst Earnings Estimates
NASDAQ:TCRT - Nasdaq - US98973P3091 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 398K | 2.922M 634.17% | 5K -99.83% | -100.00% | 568.06M | -100.00% | |||||
| EBITDA YoY % growth | -70.555M 10.95% | -32.479M 53.97% | -26.178M 19.40% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -73.152M 8.97% | -35.238M 51.83% | -28.493M 19.14% | -8.471M 70.27% | 138.77M 1,738.16% | -40.419M -129.13% | -35.895M 11.19% | -27.303M 23.94% | -26.423M 3.22% | -27.495M -4.06% | |
| Operating Margin | -18,379.90% | -1,205.95% | -569,860.00% | N/A | 24.43% | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -55.50 5.13% | -27.00 51.35% | -22.90 15.19% | -0.61 97.33% | 0.88 243.33% | -0.14 -116.28% | -0.12 14.29% | -0.09 25.00% | -0.09 | -0.09 |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.03 99.38% |
| Revenue Q2Q % growth | -100.00% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 99.49% | -0.03 | % | |
| Q1 2024 Q2Q % growth | 99.49% | -0.03 | % | |
| Q4 2023 Q2Q % growth | -4.90 18.33% | -4.59 | -0.31 | -6.75% |
| Q3 2023 Q2Q % growth | -6.00 | -5.36 | -0.64 | -12.04% |
| Q2 2023 Q2Q % growth | -6.00 20.00% | -6.73 | 0.73 | 10.87% |
| Q1 2023 Q2Q % growth | -6.00 20.00% | -6.38 | 0.38 | 5.89% |
| Q4 2022 Q2Q % growth | -6.00 20.00% | -10.20 | 4.20 | 41.18% |
| Q3 2022 Q2Q % growth | -6.00 63.64% | -11.63 | 5.63 | 48.40% |
| Q2 2022 Q2Q % growth | -7.50 54.55% | -10.45 | 2.95 | 28.26% |
| Q1 2022 Q2Q % growth | -7.50 50.00% | -10.10 | 2.60 | 25.73% |
| Q4 2021 Q2Q % growth | -7.50 54.55% | -12.90 | 5.40 | 41.84% |
| Q3 2021 Q2Q % growth | -16.50 -10.00% | -20.20 | 3.70 | 18.30% |
| Q2 2021 Q2Q % growth | -16.50 -22.22% | -18.36 | 1.86 | 10.13% |
| Q1 2021 Q2Q % growth | -15.00 -11.11% | -16.07 | 1.07 | 6.63% |
| Q4 2020 Q2Q % growth | -16.50 -22.22% | -15.11 | -1.39 | -9.21% |
| Q3 2020 Q2Q % growth | -15.00 76.74% | -13.77 | -1.23 | -8.93% |
| Q2 2020 Q2Q % growth | -13.50 | -13.99 | 0.49 | 3.49% |
| Q1 2020 Q2Q % growth | -13.50 -12.50% | -12.75 | -0.75 | -5.89% |
| Q4 2019 Q2Q % growth | -13.50 | -11.98 | -1.52 | -12.65% |
| Q3 2019 Q2Q % growth | -64.50 | -13.77 | -50.73 | -368.41% |
| Q2 2019 Q2Q % growth | -13.50 | -13.01 | -0.49 | -3.81% |
| Q1 2019 Q2Q % growth | -12.00 | -12.75 | 0.75 | 5.88% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 4K | 4K | % | |
| Q4 2023 Q2Q % growth | 1K -90.91% | 1K | % | |
| Q3 2023 Q2Q % growth | -100.00% | % | ||
| Q3 2022 Q2Q % growth | 2.911M 631.41% | 2.911M | % | |
| Q2 2019 Q2Q % growth | 1.25M | -1.25M | -100.00% | |
| Q1 2019 Q2Q % growth | 833.003K | -833.003K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |